THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Versant Capital Management, Inc's Holding History (CIK: 0001735057)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 425 Value ($000) $8 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 425 Value ($000) $6 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 425 Value ($000) $5 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 857 Value ($000) $8 Avg Close $9.31 Range $8.35 - $10.90
Q1 2021
Shares 239 Value ($000) $5 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 239 Value ($000) $4 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 239 Value ($000) $3 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 239 Value ($000) $5 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 239 Value ($000) $5 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 252 Value ($000) $6 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 308 Value ($000) $5 Avg Close $20.20 Range $16.00 - $24.34
Q1 2019
Shares 10 Value ($000) $0 Avg Close $25.36 Range $21.04 - $28.63